Diagnosis and treatment of Ileal Pouch diseases in patients with underlying ulcerative colitis

Current Treatment Options in Gastroenterology

Volumn 9, Issue 1, 2006, Pages 3-12

  Shen, Bo ^a   Lashner, Bret ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALICAFORSEN; AMITRIPTYLINE; AZATHIOPRINE; BACTERIUM LYSATE; BISMUTH; BUDESONIDE; CARBOMER; CIMETROPIUM; CIPROFLOXACIN; COLESTYRAMINE; CORTICOSTEROID; DICYCLOVERINE; DIPHENOXYLATE; GLUTAMINE; HYOSCYAMINE; INFLIXIMAB; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PLACEBO; PROBIOTIC AGENT; RIFAXIMIN; SHORT CHAIN FATTY ACID; VSL 3;

ANTIBIOTIC THERAPY; BALLOON DILATATION; BAROSTAT; CLINICAL TRIAL; CROHN DISEASE; CUFF; DEVICE INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET RESTRICTION; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG SAFETY; DRUG SUBSTITUTION; ENDOSCOPIC THERAPY; ENDOSCOPY; FISTULA; GASTROINTESTINAL IRRITATION; HISTOPATHOLOGY; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; ILEUM POUCH; MAINTENANCE THERAPY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROCTOCOLECTOMY; PROGNOSIS; RELAPSE; REMISSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SMOKING; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; ULCERATIVE COLITIS;

EID: 33645470920     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-006-0019-2     Document Type: Review

References (78)

1. Fazio VW, Ziv Y, Church JM, et al.: Ileal pouch-anal anastomosis: Complications and function in 1005 patients. Ann Surg 1995, 222:120-127.
2. Sandborn WJ: Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994, 107:1856-1860.
3. Shen B, Fazio VW, Remzi FH, et al.: Comprehensive evaluation of inflammatory and non-inflammatory sequelae of ileal pouch-anal anastomosis. Am J Gastroenterol 2005, 100:93-101.
4. Hurst RD, Molinari M, Chung TP, et al.: Prospective study of the incidence, timing, and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996, 131:497-502.
5. Meagher AP, Farouk R, Dozois RR, et al.: J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcome in 1310 patients. Br J Surg 1998, 85:800-803.
6. Penna C, Dozois R, Tremaine W, et al.: Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996, 38:234-239.
7. Simchuk EJ, Thirlby RC: Risk factors and true incidence of pouchitis in patients after ileal pouch-anal anastomosis. World J Surg 2000, 24:851-856.
8. Schmidt CM, Lazenby AJ, Hendrickson RJ, Sitzmann JV: Pre-operative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998, 227:654-662.
9. Shepherd NA, Hulten L, Tytgat GN: Pouchitis [review]. Int J Colorectal Dis 1989, 4:205-229.
10. Lohmuller JL, Pemberton HJ, Dozois RR, et al.: Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990, 211:622-629.
11. Hata K, Watanabe T, Shinozaki M, Nagawa H: Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis; Multivariate analysis. Scand J Gastroenterol 2003, 38:1055-1058.
12. Fleshner PR, Vasiliauskas EA, Kam LY, et al.: High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001, 49:671-677.
13. Kuisma J, Jarvinen H, Kahri A, Farkkilla M: Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol 2004, 39:544-548.
14. Carter K, Di Giovine FS, Cox A, et al.: The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology 2001, 121:805-811.
15. Brett PM, Yasuda N, Yiannakou JY, et al.: Genetic and immunological markers in pouchitis. Eur J Gastroenterol Hepatol 1996, 8:951-955.
16. Merrett MN, Mortensen N, Kettlewell M, Jewell DO: Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut 1996, 38:362-364.
17. Shen B, Fazio VW, Remzi FH, et al.: Risk factors for inflammatory and non-inflammatory complications of ileal pouch-anal anastomosis. Am J Gastroenterol 2004, 99:A798.
18. Achkar JP, Al-Haddad M, Lashner B, et al.: Differentiating risk factors for acute and chronic pouchitis. Clin Gastroenterol Hepatol 2005, 3:60-66.
19. Shen B, Achkar JP, Lashner BA, et al.: Endoscopic and histologic evaluations together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001, 121:261-267.
20. Moskowitz RL, Shepherd NA, Nicholls RJ: An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986, 1:167-174.
21. Sandborn WJ, Tremaine WJ, Batts KP, et al.: Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994, 69:409-415.
22. Sandborn WJ: Pouchitis: risk factors, frequency, natural history, classification and public health perspective. In Trends in Inflammatory Bowel Disease 1996. Edited by McLeod RS, Martin F, Sutherland LR, et al. Lancaster, UK: Kluwer Academic Publishers; 1997:51-63.
23. Shen B: Diagnosis and management of patients with pouchitis. Drugs 2003, 65:453-461.
24. Sandborn WJ, Pardi DS: Clinical management of pouchitis. Gastroenterology 2004, 127:1809-1814.
25. Zuccaro G, Fazio VW, Church JM, et al.: Pouch ileitis. Dig Dis Sci 1989, 34:1505-1510.
26. Shen B, Achkar JP, Lashner BA, et al.: A randomized trial of ciprofloxacin and metronidazole in treating acute pouchitis. Inflamm Bowel Dis 2001, 7:301-305.
27. Madden MV, McIntyre AS, Nicholls RJ: Double-blinded crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994, 39:1193-1196.
28. Mowschenson PM, Critchlow JF, Peppercorn MA: Ileoanal pouch operation: Long-term outcome with or without diverting ileostomy. Arch Surg 2000, 135:463-465.
29. Hurst RD, Chung TP, Rubin M, Michelassi F: Implications of acute pouchitis on the long-term functional results after restorative proctocolectomy. Inflamm Bowel Dis 1998, 4:280-284.
30. Madiba TE, Bartolo DC: Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. J R Coll Surg Edinb 2001, 46:334-337.
31. Tremaine WJ, Sandborn WJ, Wolff BG, et al.: Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997, 11:1041-1046.
32. Wischmeyer P, Pemberton JH, Philips SF: Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993, 68:978-981.
33. Sambuelli A, Boerr L, Negreira S, et al.: Budesonide enema in pouchitis: a double-blinded, double dummy, controlled trial. Aliment Pharmacol Ther 2002, 16:27-34.
34. Gionchetti P, Rizzello F, Venturi A, et al.: Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000, 119:305-309.
35. Sartor RB: Probiotics in chronic pouchitis. Restoring luminal microbial balance. Gastroenterology 2000, 119:584-585.
36. Mimura T, Rizzello F, Helwig U, et al.: Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004, 53:108-114.
37. Stahlberg D, Gullberg K, Liljeqvist L, et al.: Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996, 39:1012-1018.
38. Gionchetti P, Rizzello F, Helwig U, et al.: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003, 124:1202-1209.
39. Mann SD, Pitt J, Springall RG, Thillainayagam AV: Clostridium difficile infection - an unusual cause of refractory pouchitis: report of a case. Dis Colon Rectum 2003, 46:267-270.
40. Munoz-Juarez M, Pemberton JH, Sandborn WJ, et al.: Misdiagnosis of specific cytomegalovirus infection of ileoanal pouch as a refractory idiopathic chronic pouchitis. Report of two cases. Dis Colon Rectum 1999, 42:117-120.
41. Mooka D, Furth EE, MacDermott RP, Lichtenstein GR: Pouchitis associated with primary cytomegalovirus infection. Am J Gastroenterol 1998, 93:264-266.
42. Gionchetti P, Rizzello F, Venturi A, et al.: Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999, 13:713-718.
43. Mimura T, Rizzello R, Helwig U, et al.: Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002, 16:909-917.
44. Miner P, Wedel M, Bane B, Bradley J: An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitis. Aliment Pharmacol Ther 2004, 19:281-286.
45. Gionchetti P, Rizzello F, Morselli C, et al.: Eight-week trial of oral budesonide for the treatment of refractory pouchitis. Gastroenterology 2004, 126:A123.
46. Viscido A, Habib FI, Kohn A, et al.: Infliximab in refractory pouchitis complicated by fistulae following ileoanal pouch for ulcerative colitis. Aliment Pharmacol Ther 2003, 17:1263-1271.
47. Fazio VW, Tekkis PP, Remzi FH, et al.: Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg 2003, 238:605-617.
48. Keighley MR: The final diagnosis in pouch patients for presumed ulcerative colitis may change to Crohn's disease: patients should be warned of the consequences. Acta Chir Iugosl 2000, 47(4 Suppl 1):27-31.
49. Peyregne V, Francois Y, Gilly FN, et al.: Outcome of ileal pouch after secondary diagnosis of Crohn's disease. Int J Colorectal Dis 2000, 15:49-53.
50. Goldstein NS, Sanford WW, Bodzin JH: Crohn's-like complications in patients with ulcerative colitis after total proctocolectomy and ileal pouch-anal anastomosis. Am J Surg Pathol 1997, 21:1343-1353.
51. Deutch AA, McLeod RS, Cullen J, Cohen Z: Results of the pelvic-pouch procedure in patients with Crohn's disease. Dis Colon Rectum 1991, 34:475-477.
52. Yu CS, Pemberton JH, Larson D: Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results. Dis Colon Rectum 2000, 43:1487-1496.
53. Neilly P, Neill ME, Hill GL: Restorative proctocolectomy with ileal pouch-anal anastomosis in 203 patients: the Auckland experience. Aust N Z J Surg 1999, 69:22-27.
54. Gemlo B, Wong D, Rothenberger DA, Goldberg SM: Ileal pouch-anal anastomosis: patterns of failure. Arch Surg 1992, 127:784-787.
55. Panis Y, Poupard B, Nemeth J, et al.: Ileal pouch-anal anastomosis for Crohn's disease. Lancet 1996, 347:854-857.
56. Hartley JE, Fazio VW, Femzi FH, et al.: Analysis of the outcome of ileal pouch-anal anastomosis in patients with Crohn's disease. Dis Colon Rectum 2004, 47:1808-1815.
57. Delaney CP, Remzi FH, Gramlich T, et al.: Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis. Ann Surg 2002, 236:43-48.
58. Hyman NH, Fazio VW, Tuckson WB, Lavery IC: Consequences of ileal pouch-anal anastomosis for Crohn's colitis. Dis Colon Rectum 1991, 34:653-657.
59. Wolf JM, Achkar JF, Lashner BA, et al.: Afferent limb ulcers predict Crohn's disease in patients with ileal pouch-anal anastomosis. Gastroenterology 2004, 126:1686-1691.
60. Shen B, Fazio VF, Remzi FH, et al.: Endoscopic balloon dilation of ileal pouch strictures. Am J Gastroenterol 2004, 99:2340-2347.
61. Colombel JF, Richart E, Loftus EV, et al.: Management of Crohn's disease of the ileoanal pouch with infliximab. Am J Gastroenterol 2003, 98:2239-2244.
62. Alexander F, Sarigol S, DiFiore J, et al.: Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis. J Pediatr Surg 2003, 38:78-82.
63. Sagar PM, Dozois RR, Wolff BG: Long-term results of ileal pouch-anal anastomosis in patients with Crohn's disease. Dis Colon Rectum 1996, 39:893-898.
64. Grobler SP, Hosie KB, Affie E, et al.: Outcome of restorative proctocolectomy when the diagnosis is suggestive of Crohn's disease. Gut 1993, 34:1384-1388.
65. Tulchinsky H, Hawley PR, Nicholls J: Long-term failure after restorative proctocolectomy for ulcerative colitis. Ann Surg 2003, 238:229-234.
66. Heald RJ, Allen DR: Stapled ileo-anal anastomosis: a technique to avoid mucosal proctectomy in the ileal pouch operation. Br J Surg 1986, 73:571-572.
67. Ziv Y, Fazio VW, Sirimarco MT, et al.: Incidence, risk factors, and treatment of dysplasia in the anal transitional zone after ileal pouch-anal anastomosis. Dis Colon Rectum 1994, 37:1281-1285.
68. Williams NS: Stapling technique for pouch-anal anastomosis without the need for purse-string stricture. Br J Surg 1989, 76:348-349.
69. Lavery IC, Sirimarco MT, Ziv T, Fazio VW: Anal canal inflammation after ileal pouch-anal anastomosis. The need for treatment. Dis Colon Rectum 1995, 38:803-806.
70. Kmiot WA, Keighley MR: Totally stapled abdominal restorative proctocolectomy. Br J Surg 1989, 76:961-964.
71. Shen B, Lashner BA, Bennett A, et al.: Treatment of rectal cuff inflammation (cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis. Am J Gastroenterol 2004, 99:1527-1531.
72. Remzi FH, Fazio VW, Delaney CP, et al.: Dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of prospective evaluation after a minimum of ten years. Dis Colon Rectum 2003, 46:6-13.
73. O'Riordain MG, Fazio VW, Lavery IC, et al.: Incidence and natural history of dysplasia of the anal transitional zone after ileal pouch-anal anastomosis: results of a five-year to ten-year follow-up. Dis Colon Rectum 2000, 43:1660-1665.
74. Shen B, Achkar JP, Lashner BA, et al.: Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002, 97:972-977.
75. Bayless TM: Coexistent irritable bowel syndrome and inflammatory bowel disease. In Advanced Therapy of Inflammatory Bowel Disease, edn 1. Edited by Bayless TM, Hanauer SB. Hamilton, Ontario: B.C. Decker, 2001:91-94.
76. Bernstein CN, Rollandilli R, Niazi N, et al.: Characterization of afferent mechanisms in ileoanal pouches. Am J Gastroenterol 1997, 92:103-108.
77. Steen J, Penning C, Brussee J, et al.: Prospective evaluation of ileoanal pouch characteristics measured by barostat. Dis Colon Rectum 2002, 45:1295-1303.
78. Shen B, Sanmiguel C, Parsi M, et al.: Irritable pouch syndrome (IPS) is characterized by visceral hypersensitivity and poor quality of life (QOL) score. Gastroenterology 2004, 126(Suppl 2):A124.